# US cannabis regulatory and market developments > Live situation record from CLSTR: https://clstr.news/situations/us-cannabis-regulatory-and-market-developments > Updated: 2026-09-22T00:57:10.000Z. Sources: 4. Developments: 2. The cannabis industry is navigating significant regulatory changes and market growth. In the United States, the federal rescheduling of cannabis to a Schedule III substance is serving as a major regulatory catalyst, potentially improving research opportunities and addressing tax burdens, though tax relief is not immediate. Regional regulatory tensions are emerging, particularly in Ohio. Hemp manufacturers have raised concerns regarding Senate Bill 56, alleging a double standard in how the state regulates hemp versus marijuana dispensaries. Business owners argue that enforcement unfairly targets hemp-based businesses compared to corporate-backed marijuana dispensaries. The Ohio Department of Commerce has responded that its regulatory role is focused on marijuana, noting that previous legalization did not include intoxicating hemp. Market activity remains robust, with Florida reporting significant medical marijuana sales and a rising patient count in 2026. Additionally, professional engagement continues through events like the Ohio Cannabis Health & Business Summit, which addresses cultivation, retail, and legislative changes. ## Timeline ### 2026-09-22: Ohio cannabis industry faces regulatory disputes and upcoming business summit Ohio hemp businesses allege regulatory double standards under Senate Bill 56, while the state prepares for the 2026 Ohio Cannabis Health & Business Summit in Columbus. 2 sources. https://clstr.news/cluster/ohio-cannabis-industry-faces-regulatory-disputes-and-upcoming-business-summit ### 2026-09-07: Cannabis industry sees regulatory shifts and rising medical sales The cannabis industry faces regulatory shifts following federal rescheduling to Schedule III, alongside rising medical sales in Florida and legal developments regarding hemp restrictions in Ohio. 2 sources. https://clstr.news/cluster/cannabis-industry-sees-regulatory-shifts-and-rising-medical-sales --- Cite as: US cannabis regulatory and market developments. CLSTR, https://clstr.news/situations/us-cannabis-regulatory-and-market-developments